Surgalign Appoints David Lyle As Chief Financial Officer

Surgalign Holdings, a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced the appointment of David Lyle, as Chief Financial Officer, effective immediately. Surgalign acquired UF startup and Sid Martin Biotech alum RTI Surgical in 2020.

“David brings a wealth of experience in helping to guide the growth of technologies to Surgalign at an important and exciting inflection point of the company’s evolution,” said Terry Rich, Surgalign’s president and chief executive officer. “David is joining Surgalign at a critical time as we transition to the early commercial stage of our HOLO AI technology platform, with recent FDA clearance of our HOLO Portal™ surgical guidance system. We believe David’s extensive financial acumen, corporate development successes, and experience launching novel technologies will be immediately impactful, and on behalf of our employees and the board of directors I would like to warmly welcome him to our team.”

Read more about Surgalign Appoints David Lyle As Chief Financial Officer.